JP6524071B2 - 心臓拡張を補助するための方法および装置 - Google Patents
心臓拡張を補助するための方法および装置 Download PDFInfo
- Publication number
- JP6524071B2 JP6524071B2 JP2016519922A JP2016519922A JP6524071B2 JP 6524071 B2 JP6524071 B2 JP 6524071B2 JP 2016519922 A JP2016519922 A JP 2016519922A JP 2016519922 A JP2016519922 A JP 2016519922A JP 6524071 B2 JP6524071 B2 JP 6524071B2
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- flexible shaft
- cutting
- cutting member
- distal end
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title description 26
- 230000010343 cardiac dilation Effects 0.000 title 1
- 210000002216 heart Anatomy 0.000 claims description 38
- 230000008878 coupling Effects 0.000 claims description 23
- 238000010168 coupling process Methods 0.000 claims description 23
- 238000005859 coupling reaction Methods 0.000 claims description 23
- 210000004872 soft tissue Anatomy 0.000 claims description 16
- 239000004020 conductor Substances 0.000 claims description 6
- 239000012811 non-conductive material Substances 0.000 claims description 5
- 238000005259 measurement Methods 0.000 claims description 2
- 230000006698 induction Effects 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 36
- 210000004165 myocardium Anatomy 0.000 description 16
- 206010007559 Cardiac failure congestive Diseases 0.000 description 15
- 230000006378 damage Effects 0.000 description 11
- 208000014674 injury Diseases 0.000 description 11
- 230000001225 therapeutic effect Effects 0.000 description 11
- 210000005240 left ventricle Anatomy 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 208000003037 Diastolic Heart Failure Diseases 0.000 description 8
- 206010019280 Heart failures Diseases 0.000 description 8
- 230000002861 ventricular Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 230000003205 diastolic effect Effects 0.000 description 6
- 239000002872 contrast media Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000003384 imaging method Methods 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000005242 cardiac chamber Anatomy 0.000 description 4
- 210000005003 heart tissue Anatomy 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 description 3
- 206010052337 Diastolic dysfunction Diseases 0.000 description 3
- 208000008253 Systolic Heart Failure Diseases 0.000 description 3
- 238000002679 ablation Methods 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 210000001174 endocardium Anatomy 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- TYLVGQKNNUHXIP-MHHARFCSSA-N 10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=4C=CC=CC=4)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 TYLVGQKNNUHXIP-MHHARFCSSA-N 0.000 description 2
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 229940123237 Taxane Drugs 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- RJURFGZVJUQBHK-UHFFFAOYSA-N actinomycin D Natural products CC1OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C2CCCN2C(=O)C(C(C)C)NC(=O)C1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)NC4C(=O)NC(C(N5CCCC5C(=O)N(C)CC(=O)N(C)C(C(C)C)C(=O)OC4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-UHFFFAOYSA-N 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 238000004070 electrodeposition Methods 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 description 2
- 229960002930 sirolimus Drugs 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- TYLVGQKNNUHXIP-IDZUEFMLSA-N 10-Deacetyl-7-epi-taxol Natural products O=C(O[C@@H]1C(C)=C2[C@@H](O)C(=O)[C@@]3(C)[C@H](O)C[C@@H]4[C@@](OC(=O)C)([C@H]3[C@H](OC(=O)c3ccccc3)[C@](O)(C2(C)C)C1)CO4)[C@H](O)[C@@H](NC(=O)c1ccccc1)c1ccccc1 TYLVGQKNNUHXIP-IDZUEFMLSA-N 0.000 description 1
- 229930182986 10-Deacetyltaxol Natural products 0.000 description 1
- TYLVGQKNNUHXIP-DIYBZAJCSA-N 7-epi 10-desacetyl paclitaxel Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=4C=CC=CC=4)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 TYLVGQKNNUHXIP-DIYBZAJCSA-N 0.000 description 1
- YWLXLRUDGLRYDR-LUPIKGFISA-N 7-epi-10-deacetylbaccatin iii Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-LUPIKGFISA-N 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010092160 Dactinomycin Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- HKVAMNSJSFKALM-GKUWKFKPSA-N Everolimus Chemical compound C1C[C@@H](OCCO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 HKVAMNSJSFKALM-GKUWKFKPSA-N 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 1
- ORKLEZFXASNLFJ-DYLQFHMVSA-N O([C@H]1C[C@H]2OC[C@]2([C@@H]2[C@]1(C)C([C@H](O)C1=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=3C=CC=CC=3)C=3C=CC=CC=3)C[C@@](C1(C)C)(O)[C@H]2OC(=O)C=1C=CC=CC=1)=O)OC(=O)C)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O Chemical compound O([C@H]1C[C@H]2OC[C@]2([C@@H]2[C@]1(C)C([C@H](O)C1=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=3C=CC=CC=3)C=3C=CC=CC=3)C[C@@](C1(C)C)(O)[C@H]2OC(=O)C=1C=CC=CC=1)=O)OC(=O)C)[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O ORKLEZFXASNLFJ-DYLQFHMVSA-N 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 206010037368 Pulmonary congestion Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- NRTOMJZYCJJWKI-UHFFFAOYSA-N Titanium nitride Chemical compound [Ti]#N NRTOMJZYCJJWKI-UHFFFAOYSA-N 0.000 description 1
- RJURFGZVJUQBHK-IIXSONLDSA-N actinomycin D Chemical compound C[C@H]1OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]2CCCN2C(=O)[C@@H](C(C)C)NC(=O)[C@H]1NC(=O)C1=C(N)C(=O)C(C)=C2OC(C(C)=CC=C3C(=O)N[C@@H]4C(=O)N[C@@H](C(N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)=O)C(C)C)=C3N=C21 RJURFGZVJUQBHK-IIXSONLDSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 229930014667 baccatin III Natural products 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- 238000013172 carotid endarterectomy Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- -1 cephalomannin Chemical compound 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229960000640 dactinomycin Drugs 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- 229960003668 docetaxel Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 238000013171 endarterectomy Methods 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005167 everolimus Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 208000003906 hydrocephalus Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008383 multiple organ dysfunction Effects 0.000 description 1
- 230000010117 myocardial relaxation Effects 0.000 description 1
- 201000011107 obstructive hydrocephalus Diseases 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 239000002296 pyrolytic carbon Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002784 sclerotic effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229960001516 silver nitrate Drugs 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000000211 third ventricle Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 229950009819 zotarolimus Drugs 0.000 description 1
- CGTADGCBEXYWNE-JUKNQOCSSA-N zotarolimus Chemical compound N1([C@H]2CC[C@@H](C[C@@H](C)[C@H]3OC(=O)[C@@H]4CCCCN4C(=O)C(=O)[C@@]4(O)[C@H](C)CC[C@H](O4)C[C@@H](/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C3)OC)C[C@H]2OC)C=NN=N1 CGTADGCBEXYWNE-JUKNQOCSSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320016—Endoscopic cutting instruments, e.g. arthroscopes, resectoscopes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320783—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions through side-hole, e.g. sliding or rotating cutter inside catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B18/1492—Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3209—Incision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
- A61B2017/00247—Making holes in the wall of the heart, e.g. laser Myocardial revascularization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00184—Moving parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00345—Vascular system
- A61B2018/00351—Heart
- A61B2018/00357—Endocardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00595—Cauterization
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00601—Cutting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1405—Electrodes having a specific shape
- A61B2018/1412—Blade
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
- A61B2018/1475—Electrodes retractable in or deployable from a housing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/056—Transvascular endocardial electrode systems
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
Description
本願は、2013年9月30日に出願された特許文献1、2013年12月3日に出願された特許文献2、および、2014年9月5日に出願された特許文献3に対する優先権の利益を主張するものであり、2014年1月10日に出願された特許文献4の一部継続出願であり、それら内容全体を参照することにより本明細書に援用する。
Claims (24)
- 軟組織内に細長い切開部を生じさせるための医療装置であって、
ハンドル本体および作動部材を含むハンドルと、
前記ハンドル本体に連結される近端、および遠端を有する可撓軸と、を含み、前記可撓軸は、
前記遠端に位置を定められる非外傷性先端と、
前記可撓軸内に枢動可能に据え付けられ、刃先を有する切断部材と、
前記ハンドルの前記作動部材を前記切断部材に連結する結合部材と、を含み、前記作動部材が前記結合部材に張力を加える時、前記切断部材は、前記可撓軸の側面へ前記側面の開口部を通して枢動して、前記刃先を露出し、かつ、軟組織の切断を可能にし、前記張力によって前記可撓軸の前記遠端を前記側面の方へ偏らせて、前記軟組織内の前記刃先の維持を補助する、医療装置。 - 前記可撓軸を通して伸長する経路をさらに含む、請求項1に記載の医療装置。
- 前記結合部材は、前記切断部材の枢動点からずれている、請求項1に記載の医療装置。
- 前記可撓軸上に摺動可能に位置を定めるシースをさらに含み、前記シースを、前記開口部を覆うために進行させ、かつ、前記開口部を露出するために後退させることができる、請求項1に記載の医療装置。
- 前記切断部材は非導電材料含む、請求項1に記載の医療装置。
- 前記非導電材料上に位置を定める少なくとも1つの電極をさらに含み、前記少なくとも1つの電極は、電流源に電気的に連結可能である、請求項5に記載の医療装置。
- 前記切断部材は導電材料を含み、前記切断部材は電流源に電気的に連結可能である、請求項1に記載の医療装置。
- 前記可撓軸の前記遠端に隣接する開口部をさらに含み、前記切断部材の刃先は、枢動時に前記開口部を通して伸長する、請求項1に記載の医療装置。
- 前記開口部に隣接する電極をさらに含む、請求項8に記載の医療装置。
- 前記可撓軸の前記遠端に硬質部をさらに含み、前記硬質部は開口部を含み、該開口部を通って、前記切断部材の前記刃先が枢動時に伸長する、請求項1に記載の医療装置。
- 前記硬質部は導電材料を含み、電流源に連結可能である、請求項10に記載の医療装置。
- 前記硬質部は金属製エンクロージャを含む、請求項10に記載の医療装置。
- 前記切断部材は前記硬質部にあり、枢動するように構成される、請求項10に記載の医療装置。
- 前記結合部材に連結されるひずみ測定装置をさらに含む、請求項1に記載の医療装置。
- 前記結合部材は、前記張力を加える際に前記可撓軸の前記遠端を偏らせる際に補助するために、前記可撓軸の軸からずれている、請求項1に記載の医療装置。
- 前記可撓軸の前記遠端に位置を定める非外傷性先端をさらに含む、請求項1に記載の医療装置。
- 前記非外傷性先端は、湾曲した弾性部材を含む、請求項16に記載の医療装置。
- 前記非外傷性先端は放射線不透過性を有する、請求項16に記載の医療装置。
- 前記切断部材は、前記側面へ枢動する際に解放可能に固定できることで、前記切断部材が前記可撓軸と相対的な角度の範囲で調節可能なようにし、前記角度の範囲を、前記軟組織における切断の深さを調節するために変化させることができる、請求項1に記載の医療装置。
- 前記結合部材に連結される止め具をさらに含み、前記止め具は前記切断部材の枢動を制限する、請求項19に記載の医療装置。
- 前記可撓軸は、編組をさらに含むことで、前記可撓軸の回転時の剛性を改善するようにする、請求項1に記載の医療装置。
- 前記可撓軸はガイドワイヤ用内腔をさらに含む、請求項1に記載の医療装置。
- 前記可撓軸は心臓内への前記医療装置の布置を容易にするように成形される、請求項1に記載の医療装置。
- 請求項1に記載の医療装置と、
1つまたは複数の誘導用カテーテルと、を含む、キット。
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361884332P | 2013-09-30 | 2013-09-30 | |
US61/884,332 | 2013-09-30 | ||
US201361911456P | 2013-12-03 | 2013-12-03 | |
US61/911,456 | 2013-12-03 | ||
US14/152,189 US10772678B2 (en) | 2013-09-30 | 2014-01-10 | Methods and devices for diastolic assist |
US14/152,189 | 2014-01-10 | ||
US201462046863P | 2014-09-05 | 2014-09-05 | |
US62/046,863 | 2014-09-05 | ||
PCT/US2014/058438 WO2015048794A1 (en) | 2013-09-30 | 2014-09-30 | Methods and devices for diastolic assist |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017500064A JP2017500064A (ja) | 2017-01-05 |
JP6524071B2 true JP6524071B2 (ja) | 2019-06-05 |
Family
ID=52744614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016519922A Active JP6524071B2 (ja) | 2013-09-30 | 2014-09-30 | 心臓拡張を補助するための方法および装置 |
Country Status (6)
Country | Link |
---|---|
US (2) | US10765447B2 (ja) |
EP (1) | EP3052031A4 (ja) |
JP (1) | JP6524071B2 (ja) |
AU (2) | AU2014324479A1 (ja) |
CA (1) | CA2925933A1 (ja) |
WO (1) | WO2015048794A1 (ja) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3052031A4 (en) | 2013-09-30 | 2017-05-17 | Cordynamix, Inc. | Methods and devices for diastolic assist |
US10772678B2 (en) | 2013-09-30 | 2020-09-15 | Michael D. Laufer | Methods and devices for diastolic assist |
US10864014B2 (en) * | 2013-12-03 | 2020-12-15 | Cordynamix, Inc. | Methods and devices for diastolic assist |
WO2023229940A1 (en) * | 2022-05-26 | 2023-11-30 | Edwards Lifesciences Corporation | Pericardial transection device with retractable cutting apparatus |
WO2023229938A1 (en) * | 2022-05-26 | 2023-11-30 | Edwards Lifesciences Corporation | Pericardial transection device with retractable cutting apparatus |
WO2023229937A1 (en) * | 2022-05-26 | 2023-11-30 | Edwards Lifesciences Corporation | Pericardical transection devices and method |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2541246A (en) | 1948-07-31 | 1951-02-13 | American Cystoscope Makers Inc | Surgical instrument |
US4232676A (en) * | 1978-11-16 | 1980-11-11 | Corning Glass Works | Surgical cutting instrument |
US5125928A (en) * | 1989-04-13 | 1992-06-30 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5071424A (en) | 1989-08-18 | 1991-12-10 | Evi Corporation | Catheter atherotome |
US5074871A (en) | 1989-12-07 | 1991-12-24 | Evi Corporation | Catheter atherotome |
US5120323A (en) * | 1990-01-12 | 1992-06-09 | Schneider (Usa) Inc. | Telescoping guide catheter system |
US6770071B2 (en) * | 1995-06-07 | 2004-08-03 | Arthrocare Corporation | Bladed electrosurgical probe |
US5626595A (en) * | 1992-02-14 | 1997-05-06 | Automated Medical Instruments, Inc. | Automated surgical instrument |
US5306284A (en) | 1992-02-19 | 1994-04-26 | John Agee | Surgical instrument |
US5449355A (en) * | 1993-11-24 | 1995-09-12 | Valleylab Inc. | Retrograde tissue splitter and method |
US5658301A (en) * | 1995-04-26 | 1997-08-19 | Vascutech, Inc. | Self-centering valvulotome |
US5713913A (en) * | 1996-11-12 | 1998-02-03 | Interventional Technologies Inc. | Device and method for transecting a coronary artery |
US5769865A (en) | 1997-02-25 | 1998-06-23 | Surgical Insight, Inc. | Instrument and method for transection of a ligament |
US7887556B2 (en) * | 2000-12-20 | 2011-02-15 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
WO2001015609A1 (en) | 1999-08-31 | 2001-03-08 | Fox Hollow Technologies | Atherectomy catheter with a rotating and telescoping cutter |
US6652551B1 (en) | 2000-07-21 | 2003-11-25 | Frederick W. Heiss | Biliary sphincter scissors |
US6582400B1 (en) * | 2000-10-24 | 2003-06-24 | Scimed Life Systems, Inc. | Variable tip catheter |
US20050277968A1 (en) * | 2004-05-28 | 2005-12-15 | Doohi Lee | Percutaneous surgical device |
JP5175264B2 (ja) * | 2006-03-13 | 2013-04-03 | バクサノ,インク. | 組織を修正する装置及び方法 |
US7918784B2 (en) | 2006-08-18 | 2011-04-05 | Microaire Surgical Instruments, Inc. | Endoscopic surgical tool with retractable blade for carpal tunnel release |
US8551129B2 (en) * | 2007-11-14 | 2013-10-08 | Todd P. Lary | Treatment of coronary stenosis |
AU2009271596B2 (en) * | 2008-07-18 | 2014-06-05 | Cook Medical Technologies Llc | Introducer for endovascular implants |
US20100133130A1 (en) | 2008-10-28 | 2010-06-03 | Union Rich Usa | Tool bag with rotatable handle |
US9364259B2 (en) | 2009-04-21 | 2016-06-14 | Xlumena, Inc. | System and method for delivering expanding trocar through a sheath |
US8652025B2 (en) | 2010-10-19 | 2014-02-18 | Michael D. Laufer | Methods and devices for diastolic assist |
US9345532B2 (en) * | 2011-05-13 | 2016-05-24 | Broncus Medical Inc. | Methods and devices for ablation of tissue |
US9339327B2 (en) * | 2011-06-28 | 2016-05-17 | Aesculap Ag | Electrosurgical tissue dissecting device |
WO2013116282A1 (en) * | 2012-01-31 | 2013-08-08 | Boston Scientific Scimed, Inc. | An endoscopic instrument having a cutting tool |
EP3052031A4 (en) | 2013-09-30 | 2017-05-17 | Cordynamix, Inc. | Methods and devices for diastolic assist |
US10772678B2 (en) | 2013-09-30 | 2020-09-15 | Michael D. Laufer | Methods and devices for diastolic assist |
-
2014
- 2014-09-30 EP EP14849955.1A patent/EP3052031A4/en not_active Withdrawn
- 2014-09-30 AU AU2014324479A patent/AU2014324479A1/en not_active Abandoned
- 2014-09-30 CA CA2925933A patent/CA2925933A1/en not_active Abandoned
- 2014-09-30 WO PCT/US2014/058438 patent/WO2015048794A1/en active Application Filing
- 2014-09-30 JP JP2016519922A patent/JP6524071B2/ja active Active
-
2016
- 2016-03-30 US US15/085,509 patent/US10765447B2/en active Active
-
2019
- 2019-06-03 AU AU2019203881A patent/AU2019203881B2/en active Active
-
2020
- 2020-07-28 US US16/941,044 patent/US11696783B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017500064A (ja) | 2017-01-05 |
CA2925933A1 (en) | 2015-04-02 |
EP3052031A4 (en) | 2017-05-17 |
US20160206345A1 (en) | 2016-07-21 |
US11696783B2 (en) | 2023-07-11 |
US10765447B2 (en) | 2020-09-08 |
AU2019203881A1 (en) | 2019-06-20 |
EP3052031A1 (en) | 2016-08-10 |
WO2015048794A1 (en) | 2015-04-02 |
US20210007773A1 (en) | 2021-01-14 |
AU2019203881B2 (en) | 2021-06-24 |
AU2014324479A1 (en) | 2016-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11696783B2 (en) | Methods and devices for diastolic assist | |
US10973572B2 (en) | Catheter for treatment of atrial flutter having single action dual deflection mechanism | |
JP5531352B2 (ja) | カテーテルアセンブリ | |
US8657815B2 (en) | Delivery system for delivering a medical device to a location within a patient's body | |
US7606609B2 (en) | Devices and methods for cardiac mapping of an annular region | |
CN103417290B (zh) | 用于血管消融的具有螺旋状端部的导管 | |
JP5162580B2 (ja) | 経中隔針アセンブリ及び方法 | |
US20120197246A1 (en) | Ablation catheter | |
JP7270605B2 (ja) | 医療デバイス | |
JP2012518470A (ja) | 非対称性二方向可動カテーテルシース | |
JP2016112422A (ja) | トレーニング処理された支持部材を有するepカテーテル、及び関連する方法 | |
US20210128190A1 (en) | Methods and devices for diastolic assist | |
US20100016784A1 (en) | Positionable medical system for positioning medical components on or within a body | |
US10772678B2 (en) | Methods and devices for diastolic assist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170919 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180117 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180703 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20180629 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20180713 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20180830 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20181130 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190104 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190402 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190426 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6524071 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |